过度O-GlcNAcylation导致心力衰竭和猝死
该研究通过构建心肌特异性过表达OGT和OGA的转基因小鼠模型,发现OGT转基因心脏O-GlcNAcylation增加,出现严重扩张型心肌病、室性心律失常和早死;而OGA转基因心脏O-GlcNAcylation降低但心功能正常,且对压力负荷诱导的病理性应激有抵抗作用。OGT与OGA杂交可挽救心肌病和早死,机制涉及线粒体复合物I活性受损。结论提示过度O-GlcNAcylation导致心肌病,减弱O-GlcNAcylation可能成为心肌病治疗新策略。
要点
- 心肌O-GlcNAcylation过度增加可导致扩张型心肌病、室性心律失常和猝死。
- 增强OGA活性可降低O-GlcNAcylation,耐受良好并减轻压力负荷诱导的病理性重构。
- 线粒体复合物I活性受损参与O-GlcNAcylation介导的心脏病理。
核心结论
- 过度O-GlcNAcylation导致心肌病,至少部分归因于线粒体能量代谢缺陷。
- 增强OGA活性耐受良好,减弱O-GlcNAcylation对压力负荷诱导的病理性重构和心力衰竭有益。
- 减弱过度O-GlcNAcylation可能成为心肌病的新型治疗途径。
研究设计与样本
- 研究构建了2种新的转基因小鼠模型,其心肌分别过表达OGT和OGA,以在不依赖病理应激的情况下控制O-GlcNAcylation。
主要发现
- OGT转基因心脏显示O-GlcNAcylation增加,并出现严重扩张型心肌病、室性心律失常和早死。
- OGA转基因心脏O-GlcNAcylation较低,但心脏功能与野生型同窝对照相同。
- OGA转基因心脏对压力负荷诱导的病理性应激有抵抗作用,应激后心肌O-GlcNAcylation水平减弱,病理性肥厚较野生型对照减少。
- OGT与OGA转基因小鼠杂交可挽救心肌病和早死,尽管心肌OGT持续升高。
- 转录组和功能研究揭示OGT转基因心脏线粒体能量代谢紊乱,复合物I活性受损;复合物I活性经OGA转基因杂交被挽救。
临床怎么用
- 增强OGA活性或减弱过度O-GlcNAcylation可能成为心肌病治疗的新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure is a leading cause of death worldwide and is associated with the rising prevalence of obesity, hypertension, and diabetes. O-GlcNAcylation (the attachment of O-linked β-N-acetylglucosamine [O-GlcNAc] moieties to cytoplasmic, nuclear, and mitochondrial proteins) is a posttranslational modification of intracellular proteins and serves as a metabolic rheostat for cellular stress. Total levels of O-GlcNAcylation are determined by nutrient and metabolic flux, in addition to the net activity of 2 enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Failing myocardium is marked by increased O-GlcNAcylation, but whether excessive O-GlcNAcylation contributes to cardiomyopathy and heart failure is unknown. METHODS: We developed 2 new transgenic mouse models with myocardial overexpression of OGT and OGA to control O-GlcNAcylation independent of pathologic stress. RESULTS: We found that OGT transgenic hearts showed increased O-GlcNAcylation and developed severe dilated cardiomyopathy, ventricular arrhythmias, and premature death. In contrast, OGA transgenic hearts had lower O-GlcNAcylation but identical cardiac function to wild-type littermate controls. OGA transgenic hearts were resistant to pathologic stress induced by pressure overload with attenuated myocardial O-GlcNAcylation levels after stress and decreased pathologic hypertrophy compared with wild-type controls. Interbreeding OGT with OGA transgenic mice rescued cardiomyopathy and premature death, despite persistent elevation of myocardial OGT. Transcriptomic and functional studies revealed disrupted mitochondrial energetics with impairment of complex I activity in hearts from OGT transgenic mice. Complex I activity was rescued by OGA transgenic interbreeding, suggesting an important role for mitochondrial complex I in O-GlcNAc-mediated cardiac pathology. CONCLUSIONS: Our data provide evidence that excessive O-GlcNAcylation causes cardiomyopathy, at least in part, attributable to defective energetics. Enhanced OGA activity is well tolerated and attenuation of O-GlcNAcylation is beneficial against pressure overload-induced pathologic remodeling and heart failure. These findings suggest that attenuation of excessive O-GlcNAcylation may represent a novel therapeutic approach for cardiomyopathy.
引用
- Umapathi P, Mesubi OO, Banerjee PS, et al. Excessive O-GlcNAcylation Causes Heart Failure and Sudden Death. Circulation. 2021. PMID: 33593071. doi:10.1161/CIRCULATIONAHA.120.051911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。